The buzz around repeated low-level red light therapy (RLRL) is growing, stemming from multiple studies coming out of China. But is it just as effective in the UK? At recent global optometry conference, Dr. Neema Ghorbani Mojarrad presented on his UK audit of the Eyerising Myopia Management Device, hinting at some exciting preliminary study results. For more on this non-optical approach to myopia control, contact an Eyerising representative or check out the Eyerising International website at https://lnkd.in/gJEnNEq4.
